ABPI

News

Report finds UK risks falling behind rivals in life sciences

A just-published report on the UK's life sciences sector "ought to ring alarm bells across government," according to the Association of the British Pharmaceutical Industry (ABPI).<

Market Access

IP is no barrier to COVID vaccine access, says industry

While proponents argue waiving IP on COVID-19 vaccines would better enable low- and middle-income countries to inoculate their populations, the pharma industry has called the proposals “unn

R&D

Government pledges to work with industry to make UK a genomi...

With initiatives like The 100,000 Genome Project, the UK has led the world on genomic research.

News

Latest ABPI code breaches reveal the risk of 'likes' on Link...

AstraZeneca (AZ), GlaxoSmithKline (GSK), Sanofi, Allergan and Britannia Pharma have been reprimanded for running advertisements that breached the Association of British Pharmaceutical Indus

Market Access

Time to ask companies why they don’t submit to NICE?

Companies can choose whether or not to submit to NICE to have their products appraised.

R&D

One year on: How is the UK’s vision of a future-proof resear...

One year ago, a UK-wide vision for the country’s future research landscape promised streamlined processes, and a patient-centred, competitive environment.